EUVIMEDEUVIMED entdecken
LeserbriefKommentarRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections

Michael W Dunne iD, Steven I Aronin, Anita F Das, Jayanti Gupta, Karthik Akinapelli, Jeanne Breen, Michael T Zelasky, Sailaja Puttagunta

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad149 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Michael W Dunne und 7 weiteren Autor:innen. Beteiligte Einrichtung: Iterum Therapeutics, Old Saybrook, Connecticut, USA. Hauptthemen laut MEDLINE: Lactams, Urinary Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Iterum Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactamsUrinary Tract InfectionsHumansAnti-Bacterial AgentsTreatment OutcomeRandomized Controlled Trials as Topic

Substanzen

Anti-Bacterial AgentsLactamssulopenem

Autor:innen und Institutionen

  • Iterum Therapeutics, Old Saybrook, Connecticut, USA.
  • Das Statistical Consulting, Guerneville, California, USA.
  • Takeda Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Johnson & Johnson, Cambridge, Massachusetts, USA.

ORCID-Profile: Michael W Dunne

Förderung

  • Iterum Therapeutics

Zitieren

APA

Dunne, M. W., Aronin, S. I., Das, A. F., Gupta, J., Akinapelli, K., Breen, J., Zelasky, M. T., & Puttagunta, S. (2023). Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad149

Vancouver

Dunne MW, Aronin SI, Das AF, Gupta J, Akinapelli K, Breen J, et al. Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad149

BibTeX
@article{Dunne2023,
  author = {Dunne, Michael W and Aronin, Steven I and Das, Anita F and Gupta, Jayanti and Akinapelli, Karthik and Breen, Jeanne and Zelasky, Michael T and Puttagunta, Sailaja},
  title = {Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad149}
}
Kostenlos starten →